![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ADVITECH ANNOUNCES THE SIGNING OF A DEFINITIVE AGREEMENT WITH JAMIESON LABORATORIES
ADVITECH ANNOUNCES THE SIGNING OF A DEFINITIVE AGREEMENT WITH JAMIESON LABORATORIES
June 22, 2006
Advitech Inc. today announced it has reached a definitive agreement with Jamieson Laboratories for the distribution of its product Dermylex in Canada. The agreement was finalized following the conclusion of a market test performed by Jamieson Laboratories, which had been announced on March 10, 2006.
Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=138279)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct